Homarylamine
Homarylamine (INN;[1] also known as 3,4-methylenedioxy-N-methylphenethylamine and MDMPEA) is a substituted phenethylamine. It is the N-methylated analog of MDPEA. Homoarylamine was patented as an antitussive in 1956,[2] but has never been used medically as such.
 | |
| Clinical data | |
|---|---|
| Other names | 1,3-benzodioxolyl-N-methyl-5-ethanamine; 3,4-methylenedioxy-N-methyl-2-phenylethylamine; Norlobivine |
| Routes of administration | Various |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H13NO2 |
| Molar mass | 179.219 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Reactions
Reaction of homoarylamine with formaldehyde gives hydrastinine.
gollark: Oh, like WHY, my esolang.
gollark: It's better than interpretation because it can be faster (generally stuff uses a hybrid approach), and than precompilation because you don't need different binaries for every arch.
gollark: .
gollark: I cannot actually be bothered
gollark: Let me just start the server for that back up.
See also
- Hydrastine, an alkaloid derivative of homarylamine
References
- "International Non-Proprietary Names for Pharmaceutical Preparations" (PDF). Chronicle of the World Health Organization. 12 (3). 1958.
- U.S. Patent 2,820,739
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.